Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes

Diabetologia

Volumn 55, Issue 4, 2012, Pages 1156-1166

  Stahlman M ^a   Pham, H T ^b   Adiels, M ^a   Mitchell, T W ^b   Blanksby, S J ^b   Fagerberg, B ^a   Ekroos, K ^c   Boren J ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c Zora Biosciences Oy   (Finland)

Author keywords

Apolipoprotein B; LDL; Lipidomics; Lipids; Mass spectrometry; VLDL

Indexed keywords

APOLIPOPROTEIN B; CERAMIDE; CHOLESTEROL; CHOLESTEROL ESTER; DIACYLGLYCEROL; HEMOGLOBIN A1C; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; PALMITIC ACID; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN; TRIACYLGLYCEROL; VACCENIC ACID; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CELL SECRETION; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTRIACYLGLYCEROLEMIA; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID COMPOSITION; LIPIDOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; SYMPTOMATOLOGY; WAIST CIRCUMFERENCE;

APOLIPOPROTEINS B; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MIDDLE AGED;

EID: 84862533697     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2444-6     Document Type: Article

References (41)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myo-cardial infarction. N Engl J Med 339:229-234
2. Saydah SH, Fradkin J, Cowie CC (2004) Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291:335-342
3. Adiels M, Taskinen MR, Packard C et al (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49:755-765
4. Adiels M, Westerbacka J, Soro-Paavonen A et al (2007) Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 50:2356-2365
5. Taskinen MR (2003) Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 46:733-749
6. Chan DC, Watts GF, Redgrave TG, Mori TA, Barrett PH (2002) Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. Metabolism 51:1041-1046
7. Riches FM, Watts GF, Naoumova RP, Kelly JM, Croft KD, Thompson GR (1998) Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity. Int J Obes Relat Metab Disord 22:414-423
8. Kontush A, Chapman MJ (2010) Lipidomics as a tool for the study of lipoprotein metabolism. Curr Atheroscler Rep 12:194-201
9. Sysi-Aho M, Vehtari A, Velagapudi VR et al (2007) Exploring the lipoprotein composition using Bayesian regression on serum lipido-mic profiles. Bioinformatics 23:i519-i528
10. Stahlman M, Ejsing CS, Tarasov K, Perman J, Boren J, Ekroos K (2009) High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877:2664-2672
11. Ekroos K, Janis M, Tarasov K, Hurme R, Laaksonen R (2010) Lipidomics: a tool for studies of atherosclerosis. Curr Atheroscler Rep 12:273-281
12. Brohall G, Behre CJ, Hulthe J, Wikstrand J, Fagerberg B (2006) Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests. Diabetes Care 29:363-367
13. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO Consultation. Part I: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
14. 2O/sucrose or in KBr. J Lipid Res 49:481-490
15. Hulthe J, Wiklund O, Olsson G et al (1999) Computerized measurement of LDL particle size in human serum. Reproducibility studies and evaluation of LDL particle size in relation to metabolic variables and the occurrence of atherosclerosis. Scand J Clin Lab Investig 59:649-661
16. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509
17. Haversen L, Danielsson KN, Fogelstrand L, Wiklund O (2009) Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis 202:382-393
18. Storey JD, Tibshirani R (2003) Statistical significance for genome-wide studies. Proc Natl Acad Sci USA 100:9440-9445
19. Stevens RJ, Kothari V, Adler AI, Stratton IM (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 101:671-679
20. Ibdah JA, Lund-Katz S, Phillips MC (1989) Molecular packing of high-density and low-density lipoprotein surface lipids and apoli-poprotein A-I binding. Biochemistry 28:1126-1133
21. Sola R, Baudet MF, Motta C, Maille M, Boisnier C, Jacotot B (1990) Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids. Biochim Biophys Acta 1043:43-51
22. Gesquiere L, Cho W, Subbaiah PV (2002) Role of group IIa and group V secretory phospholipases A(2) in the metabolism of lip-oproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin. Biochemistry 41:4911-4920
23. Pettersson C, Fogelstrand L, Rosengren B et al (2008) Increased lipolysis by secretory phospholipase A(2) group V of lipoproteins in diabetic dyslipidaemia. J Intern Med 264:155-165
24. 2+-de- pendent sphingomyelinase activity in the serum of patients with type 2 diabetes is elevated. Horm Metab Res 35:506-507
25. Hiukka A, Stahlman M, Pettersson C et al (2009) ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan. Diabetes 58:2018-2026
26. Ohvo H, Olsio C, Slotte JP (1997) Effects of sphingomyelin and phosphatidylcholine degradation on cyclodextrin-mediated cholesterol efflux in cultured fibroblasts. Biochim Biophys Acta 1349:131-141
27. Shmueli E, Alberti KG, Record CO (1993) Diacylglycerol/protein kinase C signalling: a mechanism for insulin resistance? J Intern Med 234:397-400
28. Nagle CA, An J, Shiota M et al (2007) Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance. J Biol Chem 282:14807-14815
29. Glomset JA (1962) The mechanism of the plasma cholesterol esterification reaction: plasma fatty acid transferase. Biochim Bio-phys Acta 65:128-135
30. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H (1994) The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43:1353-1357
31. Pelikanova T, Kazdova L, Chvojkova S, Base J (2001) Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients. Metabolism 50:1472-1478
32. Kotronen A, Velagapudi VR, Yetukuri L et al (2009) Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 52:684-690
33. Reichwald-Hacker I, Kiewitt I, Ilsemann K, Mukherjee KD (1979) Vaccenic acid in tissue lipids and its positional distribution in glycerolipids of rats fed a polyunsaturated fat diet. J Nutr 109:565-572
34. Adiels M, Olofsson SO, Taskinen MR, Boren J (2008) Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28:1225-1236
35. Norata GD, Grigore L, Raselli S et al (2006) Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: molecular mechanisms and gene expression studies. J Mol Cell Cardiol 40:484-494
36. Williams CM, Maitin V, Jackson KG (2004) Triacylglycerol-rich lipoprotein-gene interactions in endothelial cells. Biochem Soc Trans 32:994-998
37. El-Assaad W, Buteau J, Peyot ML et al (2003) Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144:4154-4163
38. Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY (2003) Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 52:726-733
39. D'Agostino RB Jr, Hamman RF, Karter AJ, Mykkanen L, Wagenknecht LE, Haffner SM (2004) Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care 27:2234-2240
40. The DECODE Study Group (2003) Age-and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 26:61-69
41. Niskanen L, Turpeinen A, Penttila I, Uusitupa MI (1998) Hyper-glycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. Diabetes Care 21:1861-1869